4.7 Article

Fluorescent carbon dots as an efficient siRNA nanocarrier for its interference therapy in gastric cancer cells

Journal

JOURNAL OF NANOBIOTECHNOLOGY
Volume 12, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12951-014-0058-0

Keywords

Carbon dots; siRNA interference therapy; Gastric cancer; Nanocarriers

Funding

  1. Chinese Key Basic Research Program (973 Project) [2010CB933901]
  2. National Natural Scientific Foundation of China [31170961, 81225010, 81327002]
  3. 863 project of China [2012AA022703, 2014AA020700]
  4. Shanghai Science and Technology Fund [13NM1401500]
  5. Biomedical and Engineering Multidisciplinary Funding of SJTU [YG2012MS13]
  6. [YG2014MS01]

Ask authors/readers for more resources

Background: Fluorescent carbon dots (Cdots) have attracted increasing attention due to their potential applications in sensing, catalysis, and biomedicine. Currently, intensive research has been concentrated on the synthesis and imaging-guided therapy of these benign photoluminescent materials. Meanwhile, Cdots have been explored as nonviral vector for nucleic acid or drug delivery by chemical modification on purpose. Results: We have developed a microwave assisted one-step synthesis of Cdots with citric acid as carbon source and tryptophan (Trp) as both nitrogen source and passivation agent. The Cdots with uniform size show superior water solubility, excellent biocompatibility, and high quantum yield. Afterwards, the PEI (polyethylenimine)-adsorbed Cdots nanoparticles (Cdots@PEI) were applied to deliver Survivin siRNA into human gastric cancer cell line MGC-803. The results have confirmed the nanocarrier exhibited excellent biocompatibility and a significant increase in cellular delivery of siRNA, inducing efficient knockdown for Survivin protein to 6.1%. In addition, PEI@Cdots complexes mediated Survivin silencing, the arrested cell cycle progression in G(1) phase as well as cell apoptosis was observed. Conclusion: The Cdots-based and PEI-adsorbed complexes both as imaging agents and siRNA nanocarriers have been developed for Survivin siRNA delivery. And the results indicate that Cdots-based nanocarriers could be utilized in a broad range of siRNA delivery systems for cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available